1. Accueil
  2. Geneviève Waeterloos
  3. Geneviève Waeterloos

Onglets principaux

Rechercher
Limit to
Exporter 58 resultats:
Filtres: Auteur is Geneviève Waeterloos
2017
An application of mass spectrometry for quality control of biologicals: Highly sensitive profiling of plasma residuals in human plasma-derived immunoglobulin., Limonier, Franck, Van Steendam Katleen, Waeterloos Geneviève, Brusselmans Koen, Sneyers Myriam, and Deforce Dieter , J Proteomics, 2017 Jan 30, Volume 152, p.312-320, (2017)
2016
Belgium, a WHO contracted laboratorium, Waeterloos, Geneviève , Global network of national vaccine control lab, WHO Workshop, 29/8/2016, Issue WHO, NA, (2016)
OMCL's role in OOS evaluation and communication with partners (network, MAH and beyond) and tools available, Waeterloos, Geneviève , OMCL Annual Meeting 2016, 27/5/2016, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, NA, (2016)
Tetravac/Pentavac vaccines: follow-up on the aP immunogenicity assay situation, Domicent, C., Lejeune M., Stygelbout V., Brusselmans Koen, and Waeterloos Geneviève , OMCL ANNUAL MEETING 2016, 26/5/2016, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, NA, (2016)
2015
Accelerated development of vaccine benefit-risk collaboration in Europe, van der Aa, Lieke Maria, Mahy Patrick, Lernout Tinne, and Waeterloos Geneviève , Annual OMCL meeting, 0/6/2015, Issue EDQM, NA, (2015)
Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mind-set of the manufacturer., Van Molle, Wim, Tesolin L., Brusselmans Koen, and Waeterloos Geneviève , PDA Europe Conference Vaccines. Featuring WHO on Challenges in Vaccines Supply to Developing Countries, 0/11/2015, Issue PDA Europe, Berlin, Germany, (2015)
Het Wetenschappelijk Instituut Volksgezondheid (WIV-ISP) organiseert de 20e bijeenkomst van het Europese netwerk van de Official Medicines Control Laboratories (OMCL), Waeterloos, Geneviève , 06/2015, Brussels, Belgium, (2015)
Impact on the Immmunogenicity and Safety of Tetanus Toxoid Vaccine in Controlled Temperature Chain and Standard Cold chain (WHO/Epicentre project), Waeterloos, Geneviève , Quality control and batch release of vaccines and blood products in Europe, 0/0/2015, Issue WIV-ISP, (2015)
Le WIV-ISP organise la 20ème assemblée du réseau européen des Laboratoires Officiels de Contrôle des Médicaments (OMCL), Waeterloos, Geneviève , 0/6/2015, Brussel, Belgium, (2015)
The Quality Control of Plasma-Derived Medicinal Products, Carabin, O., and Waeterloos Geneviève , Quality control and batch release of vaccines and blood products in Europe, 0/0/2015, Issue WIV-ISP, NA, (2015)
Semaine de la vaccination, Waeterloos, Geneviève , 0/4/2015, Brussels, Belgium, (2015)
Semaine mondiale de la vaccination 2015 : combler les lacunes en matière de vaccination, Waeterloos, Geneviève , 0/4/2015, Brussel, Belgium, (2015)
Validation of a new reference lot for the serology of an acellular pertussis vaccine, Stygelbout, V., Dobly Alexandre, Domicent C., Dubois E., Ribaucour F, and Waeterloos Geneviève , EUpert Strain/Genomics, 0/0/2015, Issue Universitair Ziekenhuis Brussel, WIV-ISP, (2015)
Wereldwijde vaccinatieweek 2015: de vaccinatiekloof dichten, Waeterloos, Geneviève , 0/4/2015, Brussels, Belgium, (2015)
2014
The implementation of batch release for Hexacima/Hexyon/Hexaxim, Waeterloos, Geneviève , Annual OMCL meeting, 0/0/2014, Issue EDQM, NA, (2014)
Les vaccins : contrôles approfondis, Dobly, Alexandre, Brusselmans Koen, Tesolin L., and Waeterloos Geneviève , Vaxinfo, 3/9/2014, Volume 69, Number 10, p.7 - 10, (2014)
Mass spectrometry-based proteomics for the quality control of intravenous immunoglobulin: Detection of possible thrombogenic impurities, Limonier, Franck, Van Steendam K., Waeterloos Geneviève, Sneyers Myriam, and Deforce D. , 13th Human ProteomeOrgonization world congres: The proteome quest to understand biology and disease, 5/10/2014, Issue Human proteome organization, (2014)
The role of the European OMCL network in the polio eradication programm : the example of the Belgian OMCL5114, Janssen, M, and Waeterloos Geneviève , Translational and Regulatory Science of Polio Vaccines and Antivirals" worshop, 0/0/2014, Issue NIH, NA, (2014)
Veiligheid vaccins - Verregaande controle, Dobly, Alexandre, Brusselmans Koen, Tesolin L., and Waeterloos Geneviève , Vaxinfo, 3/9/2014, Volume 69, Number 10, p.7 - 10, (2014)
2013
European accreditation bodies require the OMCL participation in proficiency studies independently of the performance of blind testing: a trend or a reality, Waeterloos, Geneviève, and Van Molle Wim , Annual OMCL meeting, 12/6/2013, Issue EDQM, NA, (2013)
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation., Van Molle, Wim, Brusselmans Koen, Tesolin L., and Waeterloos Geneviève , Modern Vaccines/adjuvants Formulation: Impact On Future Development, 17/5/2013, Issue Herriot,J., Vanden Bossche,G., Lausanne, Switserland, (2013)
2012
Release testing by manufacturers & Ph.Eur. compliance: lessons learnt for competent authorities. A case study: the Extractable Volume, Van Molle, Wim, and Waeterloos Geneviève , Annual OMCL meeting, 13/6/2012, Issue EDQM, NA, (2012)
2011
Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad, Zipursky, S., Boualam L., Cheikh D.O., Fournier-Caruana J., Hamid D., Janssen M, Kartoglu U., Waeterloos Geneviève, and Ronveaux O. , Vaccine, 5/8/2011, Volume 29, Issue 34, Number 5656, p.5652 - 5656, (2011)
Kwaliteitscontrole van biologische geneesmiddelen bij WIV-ISP3237, Waeterloos, Geneviève , Healthcare Executive, 0/0/2011, Volume 59, Number 3, p.1 - 3, (2011)
Le contrôle de qualité des médicaments biologiques au WIV-ISP2849, Waeterloos, Geneviève , Focus diagnostica, 0/4/2011, Volume 19, Issue 2, Number 39, p.37 - 39, (2011)

QR code

QR code for this page URL